Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis Read more
Pfizer gets US FDA approval for PREVNAR 20, pneumococcal 20-valent conjugate vaccine for adults Read more
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report Read more